Baylor Scott & White Research Institute 
Welcome,         Profile    Billing    Logout  
 3 Products   3 Diseases   3 Products   12 Trials   72 News 

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 02468101214161820
            
            
             
TT11 / Tessa Therap, UNC Lineberger Comprehensive Cancer Center, Baylor Scott & White Research Institute           
          
            
             
CD19 specific CAR T cell therapy / Baylor Scott & White Research Institute           
          
            
             
TGFBeta resistant HER2/EBV-CTLs / Baylor Scott & White Research Institute           
          
            
             
high-titer anti-Sars-CoV-2 plasma / Baylor Scott & White Research Institute